Table 3 Clinical details of organ-space SSI cases
From: Safety of early pelvic drain removal in colorectal surgery based on drainage quantity
n = 21 | |
|---|---|
With diverting loop ileostomy, n (%) | 15 (71.4) |
Day of diagnosis, median (IQR), day | 7 (5–8) |
Diagnosis opportunity (multiple allowed) | |
Physical symptoms, n (%) | 12 (57.1) |
Blood test results, n (%) | 9 (42.9) |
Change in drainage properties, n (%) | 2 (9.5) |
Isolation of microbial pathogens | |
Escherichia coli, n (%) | 4 (19.0) |
Enterococcus faecalis, n (%) | 4 (19.0) |
Enterobacter cloacae, n (%) | 2 (9.5) |
Others | 11(52.5) |
Treatment | |
Conversion to therapeutic drain, n (%) | 4 (19.0) |
Antibiotics only, n (%) | 6 (28.6) |
New drain placement with IVR, n (%) | 8 (38.1) |
Reoperation, n (%) | 3 (14.3) |